Drug Discovery | Medical XPRT
Articles & Whitepapers
-
CanaQuest Medical Corp (OTC: CANQF)
About: CanaQuest Medical is an award-winning, Clinical Stage/Life-Sciences company focused on the drug discovery and development of next-generation targeted therapeutics within the endocannabinoid system and specific brain receptors. The Company is focused on treating neurological conditions, such as epilepsy, anxiety, depression, and Post Traumatic Stress Disorder “PTSD,” including ...
-
Entrepreneur in Residence
Celdara Medical, LLC (CM) is developing a portfolio of preclinical therapeutic assets, platforms, and companies. Each of these has a different development path, and we work with many different ...
News
-
Alfa Chemistry Offers High-Quality Dexmedetomidine Hydrochloride Meeting CP & EP Standards
Having established close cooperative relations with many pharmaceutical companies, universities, and research institutions, Alfa Chemistry decided to enlarge its active pharmaceutical ingredient (API) supply continuously in the hope of providing a ...
Creative Proteomics Has Optimized Pre-treatments and Assays for Different Types of Vitamins
Pronalyse Unveils Insightful Metabolite Identification Services of Biopharmaceuticals
BOC Sciences August Promotion: Compound Docking Solutions for Drug Discovery
CanaQuest Launches Mentanine (R) (Cannabidiol + IP Formula) in the US via www.canaqueststore.com, Supported by Western University Pre-Clinical Trials Targeting Anxiety, Depression and PTSD
Equipment & Solutions
-
Showcase
Single-use Jumper Tube Sets: SterilEnz TC Connectors
ReadyCircuit jumper tube set with C-Flex ID tubing terminating with ReadyMate to SterilEnz TC connectors. Port tubing and ReadyMate single-use connectors are preconfigured into ReadyCircuits to connect with a variety of ReadyCircuit process components. Jumper assemblies are supplied gamma-irradiated with a certificate of quality. C-Flex jumpers enable tube sealing/fusing and this facilitates ...
Upcoming Events
-
Showcase
TIDES Europe 2022
Access new data & case studies from world-renowned speakers and companies across the entire landscape of oligonucleotides, peptides, mRNA, drug delivery and partnering strategies -- from discovery to market, with an emphasis on the European region.
